Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Swine flu vaccine supply expected to increase 'in short order'

A senior adviser to President Barack Obama says the government "overpromised" with the swine flu vaccine but that the vaccine supply would catch up with the demand within a week. Meanwhile, a health group established to monitor the vaccine's safety will begin work this week.

3 Nov 2009

Deaths from H1N1 rise by 700 in one week, WHO reports

The number of deaths from H1N1 (swine flu) rose by 700 in a week, to top 5,700 since the virus was first identified in April, the WHO reported Friday, Agence France-Presse reports (10/30).

2 Nov 2009

Washington Post examines role of USAID's Richard Greene

As part of its ongoing "Federal Player of the Week" series with the Partnership for Public Service, the Washington Post examines the role of Richard Greene, the head of USAID's Office of Health, Infectious Diseases, and Nutrition in the Bureau of Global Health.

2 Nov 2009

Shortage of Tamiflu in liquid form contributes to dosage errors

Two pediatric patients in Pennsylvania hospitals received overdoses of the drug Tamiflu to treat their flu symptoms because of unawareness among staff as to the concentration of the drug given in an alternative liquid form. Both children were unharmed as a result of the errors, but details of the near misses have been published in a supplementary Pennsylvania Patient Safety Advisory to raise awareness of the issue.

2 Nov 2009

A look at the odds associated with the influenza virus

What are the odds you will be one of the unlucky ones who gets the flu this year? Book of Odds has launched "Flu Week," a fascinating look at the odds associated with the influenza virus.

2 Nov 2009

Today's opinions and editorials

When conservatives scream about socialized medicine and death panels, you should tune them out. But lately conservatives have been making an argument you should hear. It's about whether we can believe Congress when it promises to raise taxes or cut spending--and, as such, whether we can believe that health care reform can actually be fiscally responsible (Jonathan Cohn, 11/2).

2 Nov 2009

The Clorox Company anounces fiscal 2010 first-quarter results

The Clorox Company today reported strong earnings growth, driven by robust gross margin expansion and modest volume growth, for its first quarter, which ended Sept. 30.

2 Nov 2009

Juvaris BioTherapeutics commences enrollment in its JVRS-100 influenza vaccine adjuvant study

Juvaris BioTherapeutics, Inc., a biotechnology company developing adjuvanted vaccines for infectious diseases, today announced that it has begun enrolling patients in a Phase 2 clinical trial of its lead compound, JVRS-100, as an adjuvant for seasonal influenza vaccines in the elderly population.

2 Nov 2009

Perrigo announces financial results for the first quarter of fiscal 2010

Perrigo Company today announced results for its first quarter ended September 26, 2009.

2 Nov 2009

Historic agreement sets national standard for containing the spread of H1N1

In a dramatic settlement seen as a novel pattern for the nation, the nation's largest nurses union and professional association, and one of the country's biggest hospital systems today announced a landmark agreement that sets a national standard on containing the spread of pandemics such as H1N1 "swine flu."

2 Nov 2009

First Edition: November 2, 2009

Today's headlines feature insights into President Obama's behind-the-scenes role in advancing the Democrats' health overhaul efforts in Congress, plus more analysis of the public insurance option.

2 Nov 2009

NIAID awards Pulmatrix $2.2M grant for developing novel influenza therapeutics

Pulmatrix, a clinical stage biotechnology company discovering and developing a new class of therapies for the treatment and prevention of infectious and progressive respiratory diseases, today announced that it has been awarded a grant for $2.2 million from the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), aimed at advancing the development of novel influenza therapeutics for the treatment of seasonal and pandemic influenza.

2 Nov 2009

Pulmatrix raises $30.2 million through Series B financing

Pulmatrix, a clinical stage biotechnology company discovering and developing a new class of therapies for the treatment and prevention of infectious and progressive respiratory diseases, today announced that it has secured $30.2 million in Series B financing. ARCH Venture Partners and Novartis Bioventures Fund co-led the round with participation from existing investors Polaris Venture Partners and 5AM Ventures.

2 Nov 2009

MTD Products and AHA team up to promote heart health and winter safety

What do sipping cocoa, snuggling under blankets and heart attacks all have in common? They are all more common during the cold winter months.

2 Nov 2009

Rap video teaches kids how to avoid getting swine flu

"Blah, blah, H1N1 blah," is what many kids hear when their parents try to teach them how to avoid getting H1N1, or the swine flu. To cut through the blahs let DocRock and his H1N1 Rap teach your kids how to avoid catching H1N1 or the regular seasonal flu.

2 Nov 2009

American Diabetes Association launches "Stop Diabetes" campaign

Americans earn a failing grade on diabetes awareness, based on survey results released today by the American Diabetes Association. In general, Americans earned a 51% when asked a series of questions about a disease so common that it strikes every 20 seconds. The survey results revealed that many diabetes myths and misconceptions still exist, while the disease's prevalence continues to rise.

2 Nov 2009

Global health organizations observe World Pneumonia Day; urge governments to take steps to fight pneumonia

Nearly 100 leading global health organizations from around the world joined forces to recognize the first-annual World Pneumonia Day on November 2 and urge governments to take steps to fight pneumonia, the world’s leading killer of young children.

2 Nov 2009

Unexpected consequences emerge in patients who are prescribed PPI medications for reflux diseases

Despite being highly effective and beneficial for many patients, unexpected consequences are emerging in patients who are prescribed proton pump inhibitors (PPIs) for reflux diseases. Physicians are warned to monitor these effects and prescribe these medications carefully, according to a new commentary published in the November 2009 issue of Otolaryngology - Head and Neck Surgery.

2 Nov 2009

MRSA bloodstream infection linked to high mortality rate

A strain of MRSA that causes bloodstream infections is five times more lethal than other strains and has shown to have some resistance to the potent antibiotic drug vancomycin used to treat MRSA, according to a Henry Ford Hospital study.

2 Nov 2009

RESPOND program to improve global perspective on emerging diseases

Experts from the University of Minnesota will soon be on the frontlines working to help developing countries better respond to emerging animal diseases that pose a threat to human health.

31 Oct 2009